{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:25:22Z","timestamp":1757618722273,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04961-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:41:31Z","timestamp":1752136891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of strict versus lenient rate control on exercise capacity in atrial fibrillation: a retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinna","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxue","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junshuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"4961_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-022-00335-z","volume":"8","author":"BJJM Brundel","year":"2022","unstructured":"Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation Nat Rev Dis Primers. 2022;8:1\u201323.","journal-title":"Atrial fibrillation. Nat Rev Dis Primers."},{"key":"4961_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-023-01913-5","volume":"22","author":"H Shu","year":"2023","unstructured":"Shu H, Cheng J, Li N, Zhang Z, Nie J, Peng Y, et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023;22:192.","journal-title":"Cardiovasc Diabetol."},{"key":"4961_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/hm.hm_27_21","volume":"6","author":"K Mavromoustakou","year":"2022","unstructured":"Mavromoustakou K, Doundoulakis I, Soulaidopoulos S, Arsenos P, Laina A, Sideris S, et al. Impact of Atrial Fibrillation on the Severity, Progress, and Disability of the Ischemic Stroke Patients. Heart and Mind. 2022;6:26.","journal-title":"Heart and Mind."},{"key":"4961_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","volume":"37","author":"SS Chugh","year":"2001","unstructured":"Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371\u20138.","journal-title":"J Am Coll Cardiol."},{"key":"4961_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16:217\u201321.","journal-title":"Int J Stroke."},{"key":"4961_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3949\/ccjm.89a.21093","volume":"89","author":"R Deshpande","year":"2022","unstructured":"Deshpande R, Al Khadra Y, Al-Tamimi R, Albast N, Labedi M. Atrial fibrillation: Rate control or rhythm control? Cleve Clin J Med. 2022;89:567\u201371.","journal-title":"Cleve Clin J Med."},{"key":"4961_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/07853890.2021.1930137","volume":"53","author":"M Alobaida","year":"2021","unstructured":"Alobaida M, Alrumayh A. Rate control strategies for atrial fibrillation. Ann Med. 2021;53:682\u201392.","journal-title":"Ann Med."},{"key":"4961_CR8","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","volume":"79","author":"AJ Camm","year":"2022","unstructured":"Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser SH, Ma C-S, et al. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79:1932\u201348.","journal-title":"J Am Coll Cardiol."},{"key":"4961_CR9","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825\u201333.","journal-title":"N Engl J Med."},{"key":"4961_CR10","doi-asserted-by":"publisher","unstructured":"Gupta D, Rienstra M, Gelder IC van, Fauchier L. Atrial fibrillation: better symptom control with rate and rhythm management. The Lancet Regional Health\u2013 Europe. 2024;37. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100801.","DOI":"10.1016\/j.lanepe.2023.100801"},{"key":"4961_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11606-010-1574-8","volume":"26","author":"TJ Bunch","year":"2011","unstructured":"Bunch TJ, Gersh BJ. Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes. J Gen Intern Med. 2011;26:531\u20137.","journal-title":"J Gen Intern Med."},{"key":"4961_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","volume":"388","author":"IC Van Gelder","year":"2016","unstructured":"Van Gelder IC, Rienstra M, Crijns HJGM, Olshansky B. Rate control in atrial fibrillation. Lancet. 2016;388:818\u201328.","journal-title":"Lancet."},{"key":"4961_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","volume":"362","author":"IC Van Gelder","year":"2010","unstructured":"Van Gelder IC, Groenveld HF, Crijns HJGM, Tuininga YS, Tijssen JGP, Alings AM, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363\u201373.","journal-title":"N Engl J Med."},{"key":"4961_CR14","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). European Heart Journal. 2024;45:3314\u2013414.","journal-title":"European Heart Journal."},{"key":"4961_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1-156.","journal-title":"Circulation."},{"key":"4961_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/clc.4960200107","volume":"20","author":"RH Ostermaier","year":"1997","unstructured":"Ostermaier RH, Lampert S, Dalla Vecchia L, Ravid S. The effect of atrial fibrillation and the ventricular rate control on exercise capacity. Clin Cardiol. 1997;20:23\u20137.","journal-title":"Clin Cardiol."},{"key":"4961_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/eurheartj\/eht429","volume":"35","author":"SR Ulimoen","year":"2014","unstructured":"Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, et al. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Heart J. 2014;35:517\u201324.","journal-title":"Eur Heart J."},{"key":"4961_CR18","first-page":"CD011197","volume":"2","author":"SS Risom","year":"2017","unstructured":"Risom SS, Zwisler A-D, Johansen PP, Sibilitz KL, Lindschou J, Gluud C, et al. Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev. 2017;2:CD011197.","journal-title":"Cochrane Database Syst Rev."},{"key":"4961_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.167.2.211","volume":"167","author":"American Thoracic Society","year":"2003","unstructured":"American Thoracic Society, American College of Chest Physicians. ATS\/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211\u201377.","journal-title":"Am J Respir Crit Care Med."},{"key":"4961_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/eurheartj\/ehw180","volume":"39","author":"M Guazzi","year":"2018","unstructured":"Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2018;39:1144\u201361.","journal-title":"Eur Heart J."},{"key":"4961_CR21","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/eurheartj\/ehy708","volume":"40","author":"JM Letnes","year":"2019","unstructured":"Letnes JM, Dalen H, Vesterbekkmo EK, Wisl\u00f8ff U, Nes BM. Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study. Eur Heart J. 2019;40:1633\u20139.","journal-title":"Eur Heart J."},{"key":"4961_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12872-019-01293-3","volume":"19","author":"F She","year":"2019","unstructured":"She F, Ma Y, Li Y, Li L, Xu W, Wang H, et al. Influence of heart rate control on exercise capacity and quality of life in patients with permanent atrial fibrillation. BMC Cardiovasc Disord. 2019;19:308.","journal-title":"BMC Cardiovasc Disord."},{"key":"4961_CR23","doi-asserted-by":"publisher","first-page":"e006662","DOI":"10.1161\/JAHA.117.006662","volume":"6","author":"MB Elshazly","year":"2017","unstructured":"Elshazly MB, Senn T, Wu Y, Lindsay B, Saliba W, Wazni O, et al. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing. J Am Heart Assoc. 2017;6:e006662.","journal-title":"J Am Heart Assoc."},{"key":"4961_CR24","doi-asserted-by":"publisher","unstructured":"\u00a0Kishihara M, Kawakami R, Fukushima N, Abe T, Takada T, Shirotani S, et al. Prognostically Optimal Heart Rate at Discharge in Hospitalized Patients With Heart Failure and Atrial Fibrillation. JACC: Advances. 2024;3. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101120.","DOI":"10.1016\/j.jacadv.2024.101120"},{"key":"4961_CR25","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/heartjnl-2016-310391","volume":"103","author":"CA Martin","year":"2017","unstructured":"Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017;103:1543\u201352.","journal-title":"Heart."},{"key":"4961_CR26","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s00421-019-04236-0","volume":"119","author":"P Schantz","year":"2019","unstructured":"Schantz P, Salier Eriksson J, Rosdahl H. The heart rate method for estimating oxygen uptake: analyses of reproducibility using a range of heart rates from commuter walking. Eur J Appl Physiol. 2019;119:2655\u201371.","journal-title":"Eur J Appl Physiol."},{"key":"4961_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/02640414.2024.2330816","volume":"42","author":"SN Li","year":"2024","unstructured":"Li SN, Peeling P, Scott BR, Peiffer JJ, Shaykevich A, Girard O. Recovery following exercise-induced fatigue: Influence of a single heart rate clamped cycling session under systemic hypoxia. Journal of Sports Sciences. 2024;42:350\u20137.","journal-title":"Journal of Sports Sciences."},{"key":"4961_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/VHRM.S215795","volume":"15","author":"M Fysekidis","year":"2019","unstructured":"Fysekidis M, Kesse-Guyot E, Valensi P, Arnault N, Galan P, Hercberg S, et al. Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study VHRM. 2019;15:463\u201375.","journal-title":"The NUTRIVASC Study. VHRM."},{"key":"4961_CR29","doi-asserted-by":"publisher","first-page":"HAE000000000000","DOI":"10.1161\/HAE.0000000000000078","volume":"14","author":"R Gopinathannair","year":"2021","unstructured":"Gopinathannair R, Chen LY, Chung MK, Cornwell WK, Furie KL, Lakkireddy DR, et al. Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association. Circ Arrhythm Electrophysiol. 2021;14:HAE0000000000000078.","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"4961_CR30","doi-asserted-by":"publisher","first-page":"euad088","DOI":"10.1093\/europace\/euad088","volume":"25","author":"LM Westergaard","year":"2023","unstructured":"Westergaard LM, Alhakak A, R\u00f8rth R, Fosb\u00f8l EL, Kristensen SL, Svendsen JH, et al. Ventricular rate in atrial fibrillation and the risk of heart failure and death. Europace. 2023;25:euad088.","journal-title":"Europace."},{"key":"4961_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373\u2013498.","journal-title":"Eur Heart J."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04961-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:08:49Z","timestamp":1757218129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04961-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4961"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04961-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the Medical Research Ethics Committee of Guangdong Provincial People\u2019s Hospital (KY2023-514), and all procedures carried out during the study period were performed in accordance with the Declaration of Helsinki. All patients provided written informed consent before the CPET. Given that this was a retrospective observational study, we did not register it on ClinicalTrial.gov.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}